Literature DB >> 15515137

Regression methods for cost-effectiveness analysis with censored data.

Andrew R Willan1, D Y Lin, Andrea Manca.   

Abstract

A system of seemingly unrelated regression equations is proposed for prognostic factor adjustment and subgroup analysis when comparing two groups in a cost-effectiveness analysis with censored data. Because of the induced dependent censoring on costs and quality-adjusted survival, inverse probability weighting is employed for parameter estimation. The method is illustrated with data from two recent examples using both survival time and quality-adjusted survival time as the measures of effectiveness. 2004 John Wiley & Sons, Ltd.

Mesh：

Substances：

Year:  2005        PMID： 15515137     DOI： 10.1002/sim.1794

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  21 in total

1.  Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting.

Authors:  Marcus A Neubauer; J Russell Hoverman; Michael Kolodziej; Lonny Reisman; Stephen K Gruschkus; Susan Hoang; Albert A Alva; Marilyn McArthur; Michael Forsyth; Todd Rothermel; Roy A Beveridge
Journal:  J Oncol Pract       Date:  2009-12-30       Impact factor: 3.840

2.  Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.

Authors:  Michael Grabner; Eberechukwu Onukwugha; Rahul Jain; C Daniel Mullins
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

Review 3.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis.

Authors:  Matthew Franklin; James Lomas; Simon Walker; Tracey Young
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

4.  Some insight on censored cost estimators.

Authors:  H Zhao; Y Cheng; H Bang
Journal:  Stat Med       Date:  2011-07-11       Impact factor: 2.373

5.  Joint modeling quality of life and survival using a terminal decline model in palliative care studies.

Authors:  Zhigang Li; Tor D Tosteson; Marie A Bakitas
Journal:  Stat Med       Date:  2012-09-23       Impact factor: 2.373

6.  Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation.

Authors:  Bernd Schweikert; Harry Hahmann; Jürgen M Steinacker; Armin Imhof; Rainer Muche; Wolfgang Koenig; Yufei Liu; Reiner Leidl
Journal:  Clin Res Cardiol       Date:  2009-10-11       Impact factor: 5.460

7.  Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial.

Authors:  Wayne Katon; Joan Russo; Elizabeth H B Lin; Julie Schmittdiel; Paul Ciechanowski; Evette Ludman; Do Peterson; Bessie Young; Michael Von Korff
Journal:  Arch Gen Psychiatry       Date:  2012-05

8.  Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer.

Authors:  Joshua A Roth; Mark E Bensink; Paul V O'Donnell; Ephraim J Fuchs; Mary Eapen; Scott D Ramsey
Journal:  J Comp Eff Res       Date:  2014-03       Impact factor: 1.744

9.  Cost effectiveness analysis of larval therapy for leg ulcers.

Authors:  Marta O Soares; Cynthia P Iglesias; J Martin Bland; Nicky Cullum; Jo C Dumville; E Andrea Nelson; David J Torgerson; Gill Worthy
Journal:  BMJ       Date:  2009-03-19

10.  Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging Trial.

Authors:  Ba' Pham; Margaret B Harrison; Maggie H Chen; Meg E Carley
Journal:  BMC Health Serv Res       Date:  2012-10-02       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.